Navigation Links
Chemvent Develops Innovative Low VOC Cleaning Product
Date:2/26/2013

Ann Arbor, MI (PRWEB) February 26, 2013

The product development scientists at Chemvent have recently completed the contract development of an innovative new all-purpose cleaner. In January, a small-business owner approached Chemvent with a challenge to fully develop a general purpose cleaner with specific property requirements.

Firstly, the client determined that product must have significant degreasing properties without leaving residue on the cleaned surface. Secondly, the product must have the proper rheology to ensure ease of use from the spray bottle. Thirdly, the product must meet the low volatile organic compound (VOC) requirements for all states. Finally, the cleaner must have a fresh fragrance.

Chemvent’s cleaning product formulation specialists accepted the challenge and began development. The scientists first investigated and identified green cleaning solutions, approved surfactants for household-use requirements, and fragrances. Special attention was given to fragrance choice, as these chemicals count towards the final VOC level, due to the requirements of EPA Method 24.

Chemvent’s product development experts created an emulsion blend using a water base and tested the degreasing properties and deposits left behind by FT-IR. The chemists then tested the formulation against various simulated household messes, according to ASTM standard methods. The formulation was revised multiple times for optimal performance.

Once testing and development was completed, Chemvent provided the client with the complete ownership of the entire formula. The cleaning product development experts at Chemvent successfully developed a product for a small-business that gave the client the freedom to manufacture and market the cleaner in all 50 states.

--

Chemvent is a custom chemical product development company. At Chemvent, clients work with Ph.D. scientists, patent professionals, and graphic designers to develop a custom product from an idea to manufacture. Development capabilities include paints and coatings, adhesives and sealants, supplements, fertilizers, pesticides, and more.

Read the full story at http://www.prweb.com/releases/chemistry/custom-formulation/prweb10461400.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. NASA develops super-black material that absorbs light across multiple wavelength bands
2. UCLA team develops highly efficient method for creating flexible, transparent electrodes
3. Ecology Coatings Develops Coatings Safe for Direct Contact with Food Products
4. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
5. Harvards Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses
6. College Chairman And Prolific Inventor Develops Life-Saving, Real-Time Diagnostic Technologies
7. Union Equity, Inc.s Wholly Owned Subsidiary Develops Cream that Aids in Soothing the Symptoms of Chemotherapy
8. Medi-Solve Coatings Develops Masking Process for Medical Devices
9. UCLA-led research team develops worlds most powerful nanoscale microwave oscillators
10. New England Biolabs Develops Novel Polymerase with Ultra-High Fidelity and Minimal GC Bias
11. IBN develops superior fuel cell material
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):